COLUMBUS, OH - February 24, 2026 - PRESSADVANTAGE - As awareness of obstructive sleep apnea continues to grow across ...

Nov 29 (Reuters) - Vivos Therapeutics (VVOS.O), opens new tab said on Wednesday the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA), leading a massive rally ...

Studies found mouth-taping significantly reduced snoring in OSA and effectively reduced AHI in patients using a mandibular advancement device. Use of nocturnal mouth-taping may have promise for sleep ...

In much the same way that they’re designed to expand wearers’ upper airways, Vivos Therapeutics’ slate of oral appliances have now expanded their FDA indications, too. Collectively known as the ...

Vivos Therapeutics (NASDAQ:VVOS) shares rallied premarket on Wednesday after the medtech firm gained first ever FDA 510(k) clearance for oral device treatment of severe obstructive sleep apnea (OSA).

Credit: Vivos Therapeutics. The FDA clearance was based on data from 73 patients with severe OSA. The Food and Drug Administration (FDA) has cleared the Vivos CARE (complete airway repositioning ...

Vivos Therapeutics Inc. shares VVOS jumped more than 270% Wednesday after the medical-device maker got regulatory clearance for removable oral appliances that treat obstructive sleep apnea. The U.S.

The popular social media trend of mouth taping during sleep may improve obstructive sleep apnea (OSA), snoring, and bilevel ventilation, but more research is needed. This review study was recently ...

HOUSTON – “What is a mouth guard” and “Sleep apnea” are trending on Google search as Americans are trying to find ways to get better sleep. If you’re on social media, then you’ve probably seen an ...